Oseltamivir Phosphate For Suspension
NDC Package 70710-1165-6

11-digit billing NDC: 70710116506 · Billing unit: ML · 60 ML per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Oseltamivir Phosphate for suspensions is oseltamivir phosphate for oral suspension is contraindicated in patients with known serious hypersensitivity to oseltamivir or any component of the product. This formulation utilizes a for suspension delivery system. Marketed by Zydus Pharmaceuticals Usa Inc., this product is identified by NDC 70710-1165 and is authorized under FDA application ANDA209113.

Identification & Billing

NDC Package Code
70710-1165-6
Package Description
1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE
Product Code
70710-1165
11-Digit Billing Format
70710116506
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
60 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Oseltamivir Phosphate
Non-Proprietary Name
Oseltamivir Phosphate
Substance Name
Oseltamivir Phosphate
Dosage Form
For Suspension - A product, usually a solid, intended for suspension prior to administration.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
OSELTAMIVIR PHOSPHATE 6 mg/mL
Pharmacologic Class
Usage Information
Oseltamivir phosphate for oral suspension is contraindicated in patients with known serious hypersensitivity to oseltamivir or any component of the product. Severe allergic reactions have included anaphylaxis and serious skin reactions including toxic epidermal necrolysis, Stevens-Johnson Syndrome, and erythema multiforme [see Warnings and Precautions (5.1)].

Regulatory & Marketing

Labeler Name
Zydus Pharmaceuticals Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA209113
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-14-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70710-1165-6 identifies a specific commercial package of 1 bottle in 1 carton / 60 ml in 1 bottle of Oseltamivir Phosphate, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. This for suspension is formulated for oral use and contains oseltamivir phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on September 14, 2017. The current certification is valid through December 31, 2027.

How is this Zydus Pharmaceuticals Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710116506. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70710-1165-6
11-Digit CMS (5-4-2)
70710-1165-06

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.